fda - Search News

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

FDA approves new pain medication as an alternative to opioids: What to know about Journavx

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

U.S. News & World Report · 3h

FDA Approves First New Non-Opioid Pain Pill in Decades

FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

Newsweek on MSN · 6h

What is Non-Opioid Pain Medication? Journavx Approved by FDA

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

Recall raised to highest risk level by FDA. What to know

People · 59m

Chocolate Recall Updated to Highest Risk Level, FDA Warns Consumption Could Cause Death

The FDA has updated the December recall of some of Cal Yee Farms' products to the highest risk level classification for three of its chocolate products, warning that exposure or consumption could cause death.

Newsweek on MSN · 2d

Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States

A recall which was issued across nine states has now been given the highest risk classification by the federal agency.

USA TODAY on MSN · 1d

FDA upgrades Frito-Lay potato chips recall to highest risk level due to undeclared milk

Federal regulators have upgraded a product recall of Lay's Classic Potato Chips to the highest risk level for a batch that may contain undeclared milk ingredients. Last month, Frito-Lay issued a recall warning that more than 6,

23h

US FDA identifies cybersecurity risks in certain patient monitors

The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks associated with ...

2don MSN

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

The American Journal of Managed Care1h

FDA Approves Celltrion’s Tocilizumab-anoh, Biosimilar to Actemra

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients.

Live Science1h

FDA approves 'ketamine' nasal spray for depression — here's everything you need to know

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.